← Open Payments lookup

OLUWADARA OSINUBI: Open Payments

NPI 1134756794 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$975 in 36 payments from 7 companies in 2025. Trend: 2023 $350 · 2024 $394 · 2025 $975

Food & beverage: $975
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.12$441
ABBVIE INC.8$177
Otsuka America Pharmaceutical, Inc.5$133
Alkermes, Inc.6$122
Lundbeck LLC3$56
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$26
Axsome Therapeutics, Inc.1$19

Products named: INGREZZA, VRAYLAR, ARISTADA, ABILIFY ASIMTUFII, REXULTI, ABILIFY MAINTENA, CAPLYTA, LYBALVI.

Industry payments across MD — which companies pay providers there.